Association between the brief inventory of neurocognitive impairment (BINI) and objective cognitive testing among persons with opioid use disorders in drug treatment

Abstract

The current study examined the association between subjective cognitive dysfunction and objective test performance in persons enrolled in drug treatment and stabilized on methadone maintenance therapy (MMT). A total of 177 participants completed the self-reported brief inventory of neurocognitive impairment (BINI) and NIH Toolbox test battery. In participants with neurocognitive dysfunction, scores on all BINI subscales were negatively associated with objective performance on the NIH Toolbox (BINI Global r = −0.26, p = 0.01; BINI Subscales ranging −0.22 to −0.32, all p’s < 0.03). Using cutoff scores, results showed participants who scored above the cutoff on the BINI Learning subscale demonstrated significant evidence of objective neurocognitive dysfunction on the NIH Toolbox (65% vs. 35%; χ² = 6.57, p = 0.02), suggesting possible clinical utility. Future studies are needed to determine the feasibility of using the BINI to inform the accommodation of patients with specific neurocognitive profiles to optimize treatment outcomes.

Keywords:

• Neurocognitive dysfunction
• cognitive impairment
• opioid-dependence
• drug treatment
• methadone maintenance therapy
• HIV

Acknowledgments

The authors thank Brian Sibilio, Pramila Karki, and Julia Sharma for the contributions to this study.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Correction Statement

This article has been republished with minor changes. These changes do not impact the academic content of the article.

Additional information

Funding

This work was supported by grants from the National Institute on Drug Abuse for research (R01DA032290 to MMC), for career development (K24DA051344 to MMC; K01DA051346 to RS), National Institute on Aging (R01AG065432 to JG), and from the National Institute of Mental Health (T32MH074387-14) to CBM.